Cargando…

Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding

Nucleic acid aptamers are ssDNA or ssRNA fragments that specifically recognize targets. However, the pharmacodynamic properties of natural aptamers consisting of 4 naturally occurring nucleosides (A, G, C, T/U) are generally restricted for inferior binding affinity than the cognate antibodies. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zefeng, Luo, Hang, Gubu, Amu, Yu, Sifan, Zhang, Huarui, Dai, Hong, Zhang, Yihao, Zhang, Baoting, Ma, Yuan, Lu, Aiping, Zhang, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996316/
https://www.ncbi.nlm.nih.gov/pubmed/36910146
http://dx.doi.org/10.3389/fcell.2023.1091809
_version_ 1784903017631318016
author Chen, Zefeng
Luo, Hang
Gubu, Amu
Yu, Sifan
Zhang, Huarui
Dai, Hong
Zhang, Yihao
Zhang, Baoting
Ma, Yuan
Lu, Aiping
Zhang, Ge
author_facet Chen, Zefeng
Luo, Hang
Gubu, Amu
Yu, Sifan
Zhang, Huarui
Dai, Hong
Zhang, Yihao
Zhang, Baoting
Ma, Yuan
Lu, Aiping
Zhang, Ge
author_sort Chen, Zefeng
collection PubMed
description Nucleic acid aptamers are ssDNA or ssRNA fragments that specifically recognize targets. However, the pharmacodynamic properties of natural aptamers consisting of 4 naturally occurring nucleosides (A, G, C, T/U) are generally restricted for inferior binding affinity than the cognate antibodies. The development of high-affinity modification strategies has attracted extensive attention in aptamer applications. Chemically modified aptamers with stable three-dimensional shapes can tightly interact with the target proteins via enhanced non-covalent bonding, possibly resulting in hundreds of affinity enhancements. This review overviewed high-affinity modification strategies used in aptamers, including nucleobase modifications, fluorine modifications (2′-fluoro nucleic acid, 2′-fluoro arabino nucleic acid, 2′,2′-difluoro nucleic acid), structural alteration modifications (locked nucleic acid, unlocked nucleic acid), phosphate modifications (phosphorothioates, phosphorodithioates), and extended alphabets. The review emphasized how these high-affinity modifications function in effect as the interactions with target proteins, thereby refining the pharmacodynamic properties of aptamers.
format Online
Article
Text
id pubmed-9996316
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99963162023-03-10 Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding Chen, Zefeng Luo, Hang Gubu, Amu Yu, Sifan Zhang, Huarui Dai, Hong Zhang, Yihao Zhang, Baoting Ma, Yuan Lu, Aiping Zhang, Ge Front Cell Dev Biol Cell and Developmental Biology Nucleic acid aptamers are ssDNA or ssRNA fragments that specifically recognize targets. However, the pharmacodynamic properties of natural aptamers consisting of 4 naturally occurring nucleosides (A, G, C, T/U) are generally restricted for inferior binding affinity than the cognate antibodies. The development of high-affinity modification strategies has attracted extensive attention in aptamer applications. Chemically modified aptamers with stable three-dimensional shapes can tightly interact with the target proteins via enhanced non-covalent bonding, possibly resulting in hundreds of affinity enhancements. This review overviewed high-affinity modification strategies used in aptamers, including nucleobase modifications, fluorine modifications (2′-fluoro nucleic acid, 2′-fluoro arabino nucleic acid, 2′,2′-difluoro nucleic acid), structural alteration modifications (locked nucleic acid, unlocked nucleic acid), phosphate modifications (phosphorothioates, phosphorodithioates), and extended alphabets. The review emphasized how these high-affinity modifications function in effect as the interactions with target proteins, thereby refining the pharmacodynamic properties of aptamers. Frontiers Media S.A. 2023-02-23 /pmc/articles/PMC9996316/ /pubmed/36910146 http://dx.doi.org/10.3389/fcell.2023.1091809 Text en Copyright © 2023 Chen, Luo, Gubu, Yu, Zhang, Dai, Zhang, Zhang, Ma, Lu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Chen, Zefeng
Luo, Hang
Gubu, Amu
Yu, Sifan
Zhang, Huarui
Dai, Hong
Zhang, Yihao
Zhang, Baoting
Ma, Yuan
Lu, Aiping
Zhang, Ge
Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title_full Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title_fullStr Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title_full_unstemmed Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title_short Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
title_sort chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996316/
https://www.ncbi.nlm.nih.gov/pubmed/36910146
http://dx.doi.org/10.3389/fcell.2023.1091809
work_keys_str_mv AT chenzefeng chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT luohang chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT gubuamu chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT yusifan chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT zhanghuarui chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT daihong chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT zhangyihao chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT zhangbaoting chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT mayuan chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT luaiping chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding
AT zhangge chemicallymodifiedaptamersforimprovingbindingaffinitytothetargetproteinsviaenhancednoncovalentbonding